123 related articles for article (PubMed ID: 10531334)
1. Serine 19 of human 6-pyruvoyltetrahydropterin synthase is phosphorylated by cGMP protein kinase II.
Scherer-Oppliger T; Leimbacher W; Blau N; Thöny B
J Biol Chem; 1999 Oct; 274(44):31341-8. PubMed ID: 10531334
[TBL] [Abstract][Full Text] [Related]
2. Autophosphorylation of cGMP-dependent protein kinase type II.
Vaandrager AB; Hogema BM; Edixhoven M; van den Burg CM; Bot AG; Klatt P; Ruth P; Hofmann F; Van Damme J; Vandekerckhove J; de Jonge HR
J Biol Chem; 2003 Aug; 278(31):28651-8. PubMed ID: 12764134
[TBL] [Abstract][Full Text] [Related]
3. Autoinhibition and isoform-specific dominant negative inhibition of the type II cGMP-dependent protein kinase.
Taylor MK; Ahmed R; Begley M; Uhler MD
J Biol Chem; 2002 Oct; 277(40):37242-53. PubMed ID: 12093798
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families.
Oppliger T; Thöny B; Kluge C; Matasovic A; Heizmann CW; Ponzone A; Spada M; Blau N
Hum Mutat; 1997; 10(1):25-35. PubMed ID: 9222757
[TBL] [Abstract][Full Text] [Related]
5. The amino-terminal cyclic nucleotide binding site of the type II cGMP-dependent protein kinase is essential for full cyclic nucleotide-dependent activation.
Taylor MK; Uhler MD
J Biol Chem; 2000 Sep; 275(36):28053-62. PubMed ID: 10864932
[TBL] [Abstract][Full Text] [Related]
6. Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism: molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin synthase.
Thöny B; Leimbacher W; Blau N; Harvie A; Heizmann CW
Am J Hum Genet; 1994 May; 54(5):782-92. PubMed ID: 8178819
[TBL] [Abstract][Full Text] [Related]
7. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.
Burkhardt M; Glazova M; Gambaryan S; Vollkommer T; Butt E; Bader B; Heermeier K; Lincoln TM; Walter U; Palmetshofer A
J Biol Chem; 2000 Oct; 275(43):33536-41. PubMed ID: 10922374
[TBL] [Abstract][Full Text] [Related]
8. The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms.
Gamm DM; Francis SH; Angelotti TP; Corbin JD; Uhler MD
J Biol Chem; 1995 Nov; 270(45):27380-8. PubMed ID: 7593002
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of a novel activity of bacterial 6-pyruvoyltetrahydropterin synthase homologues distinct from mammalian 6-pyruvoyltetrahydropterin synthase activity.
Seo KH; Zhuang N; Park YS; Park KH; Lee KH
Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1212-23. PubMed ID: 24816091
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional consequences of mutations in 6-pyruvoyltetrahydropterin synthase causing hyperphenylalaninemia in humans. Phosphorylation is a requirement for in vivo activity.
Oppliger T; Thöny B; Nar H; Bürgisser D; Huber R; Heizmann CW; Blau N
J Biol Chem; 1995 Dec; 270(49):29498-506. PubMed ID: 7493990
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cloned cardiac L-type calcium channels by cGMP-dependent protein kinase.
Jiang LH; Gawler DJ; Hodson N; Milligan CJ; Pearson HA; Porter V; Wray D
J Biol Chem; 2000 Mar; 275(9):6135-43. PubMed ID: 10692404
[TBL] [Abstract][Full Text] [Related]
12. cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2.
Isshiki K; Matsuda S; Tsuji A; Yuasa K
Biochem Biophys Res Commun; 2012 Jun; 422(2):280-4. PubMed ID: 22580283
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
Komalavilas P; Shah PK; Jo H; Lincoln TM
J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP kinase II (cGKII) inhibits NHE3 by altering its trafficking and phosphorylating NHE3 at three required sites: identification of a multifunctional phosphorylation site.
Chen T; Kocinsky HS; Cha B; Murtazina R; Yang J; Tse CM; Singh V; Cole R; Aronson PS; de Jonge H; Sarker R; Donowitz M
J Biol Chem; 2015 Jan; 290(4):1952-65. PubMed ID: 25480791
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese patients.
Imamura T; Okano Y; Shintaku H; Hase Y; Isshiki G
J Hum Genet; 1999; 44(3):163-8. PubMed ID: 10319579
[TBL] [Abstract][Full Text] [Related]
16. Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle.
Huber A; Neuhuber WL; Klugbauer N; Ruth P; Allescher HD
J Biol Chem; 2000 Feb; 275(8):5504-11. PubMed ID: 10681529
[TBL] [Abstract][Full Text] [Related]
17. Identification of a conserved residue responsible for the autoinhibition of cGMP-dependent protein kinase Ialpha and beta.
Yuasa K; Michibata H; Omori K; Yanaka N
FEBS Lett; 2000 Jan; 466(1):175-8. PubMed ID: 10648836
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated double transduction of the GTPCH and PTPS genes allows 6-pyruvoyltetrahydropterin synthase-deficient human fibroblasts to synthesize and release tetrahydrobiopterin.
Laufs S; Blau N; Thöny B
J Neurochem; 1998 Jul; 71(1):33-40. PubMed ID: 9648848
[TBL] [Abstract][Full Text] [Related]
19. Functional regulation of transient receptor potential canonical 7 by cGMP-dependent protein kinase Iα.
Yuasa K; Matsuda T; Tsuji A
Cell Signal; 2011 Jul; 23(7):1179-87. PubMed ID: 21402151
[TBL] [Abstract][Full Text] [Related]
20. A cGMP-dependent protein kinase assay for high throughput screening based on time-resolved fluorescence resonance energy transfer.
Bader B; Butt E; Palmetshofer A; Walter U; Jarchau T; Drueckes P
J Biomol Screen; 2001 Aug; 6(4):255-64. PubMed ID: 11689125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
